Gen9 Garners $1,550,001 Series B Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    500 Technology Sq. Cambridge, MA 01239
  • Company Description
    The company is developing synthetic biology technologies.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount reflects value of Series B Preferred Stock to be sold & Series B Preferred Stock underlying Warrants and Promissory Notes. Amount Sold reflects value of Preferred Stock sold. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy